Literature DB >> 22429019

Computational analysis of intersubject variability and thrombin generation in dilutional coagulopathy.

Alexander Y Mitrophanov1, Frits R Rosendaal, Jaques Reifman.   

Abstract

BACKGROUND: Blood dilution is a frequent complication of massive transfusion during trauma and surgery. This article investigates the quantitative effects of blood plasma dilution on thrombin generation in the context of intersubject variability. STUDY DESIGN AND METHODS: A thoroughly validated computational model was used to simulate thrombin generation curves for 472 healthy subjects in the Leiden Thrombophilia Study. Individual thrombin curves were calculated for undiluted blood and for different dilution scenarios. For every such curve, five standard quantitative parameters of thrombin generation were calculated and analyzed.
RESULTS: Thrombin generation parameters in diluted blood plasma displayed significant intersubject variability (with a coefficient of variation up to approx. 28%). Nevertheless, dilutional effects in the majority (or all) of the subjects in the study group were characterized by persistent patterns. In particular, the largest dilution-induced change typically occurred in the maximum slope (MS) of the thrombin curve, followed by a change in thrombin peak height (PH), whereas the smallest change often occurred in the area under the curve. The identified patterns demonstrated considerable robustness to variations in dilution scenario and tissue factor concentration.
CONCLUSION: Dilutional effects on thrombin generation in a human population can be predicted from trends identified for the "average" subject and then refined by performing an analysis of actual subjects in the study group. The MS and PH are dilution indicators that are both sensitive and reliable across a large subject group and could potentially be used as disease markers in the diagnosis of coagulopathic conditions.
© 2012 American Association of Blood Banks.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22429019     DOI: 10.1111/j.1537-2995.2012.03610.x

Source DB:  PubMed          Journal:  Transfusion        ISSN: 0041-1132            Impact factor:   3.157


  7 in total

1.  Kinetic model facilitates analysis of fibrin generation and its modulation by clotting factors: implications for hemostasis-enhancing therapies.

Authors:  Alexander Y Mitrophanov; Alisa S Wolberg; Jaques Reifman
Journal:  Mol Biosyst       Date:  2014-07-29

2.  Mathematical model of thrombin generation and bleeding phenotype in Amish carriers of Factor IX:C deficiency vs. controls.

Authors:  S Gupta; M C Bravo; M Heiman; C Nakar; K Brummel-Ziedins; C H Miller; A Shapiro
Journal:  Thromb Res       Date:  2019-08-08       Impact factor: 3.944

Review 3.  Computationally Driven Discovery in Coagulation.

Authors:  Kathryn G Link; Michael T Stobb; Dougald M Monroe; Aaron L Fogelson; Keith B Neeves; Suzanne S Sindi; Karin Leiderman
Journal:  Arterioscler Thromb Vasc Biol       Date:  2020-10-29       Impact factor: 8.311

4.  Mechanistic Modeling of the Effects of Acidosis on Thrombin Generation.

Authors:  Alexander Y Mitrophanov; Frits R Rosendaal; Jaques Reifman
Journal:  Anesth Analg       Date:  2015-08       Impact factor: 5.108

5.  Impact of Tissue Factor Localization on Blood Clot Structure and Resistance under Venous Shear.

Authors:  Vijay Govindarajan; Shu Zhu; Ruizhi Li; Yichen Lu; Scott L Diamond; Jaques Reifman; Alexander Y Mitrophanov
Journal:  Biophys J       Date:  2018-02-27       Impact factor: 4.033

6.  The prothrombotic phenotypes in familial protein C deficiency are differentiated by computational modeling of thrombin generation.

Authors:  Kathleen E Brummel-Ziedins; Thomas Orfeo; Peter W Callas; Matthew Gissel; Kenneth G Mann; Edwin G Bovill
Journal:  PLoS One       Date:  2012-09-12       Impact factor: 3.240

7.  Computational Study of Thrombus Formation and Clotting Factor Effects under Venous Flow Conditions.

Authors:  Vijay Govindarajan; Vineet Rakesh; Jaques Reifman; Alexander Y Mitrophanov
Journal:  Biophys J       Date:  2016-04-26       Impact factor: 4.033

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.